E Fund Management Co., Ltd. Passage Bio, Inc. Transaction History
E Fund Management Co., Ltd.
- $2.06 Billion
- Q2 2025
Shares
1 transactions
Others Institutions Holding PASG
# of Institutions
5Shares Held
905KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY818KShares$6.78 Million0.0% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY87.4KShares$724,7611.66% of portfolio
-
First Capital Advisors Group, Llc. Little Silver, NJ23Shares$1900.0% of portfolio
-
Cwm, LLC1Shares$80.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $451M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...